Dih Us(OTC) DHAI

Current Price$0.02

Market Cap$41.90K

Since IPO (2022)-100%

5 YearN/A

1 Year-100%

1 Month+1,233%

Dih Us last closing stock price
Metric	Price	Date
Last close	USD 0.02	2026-07-20

Dih Us stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+0%	USD 0.02	2026-07-06
1 month	+1,233.33%	USD 0.00	2026-06-18
3 month	+1,900%	USD 0.00	2026-04-21
Year to date	+354.55%	USD 0.00	2025-12-31
1 year	-99.68%	USD 6.20	2025-07-18
3 year	-99.99%	USD 267.50	2023-07-21
Since inception	-99.99%	USD 246.27	2022-03-21

Dih Us Financials at a Glance

Market Cap

$41.90K

Revenue (TTM)

$62.86M

Net Income (TTM)

-$8.68M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

8.84 (High)

Dividend

$0.00

Beta (Volatility)

8.84 (High)

Price

$0.02

Volume

Open

$0.02

Price

$0.02

Volume

Open

$0.02

Previous Close

$0.02

Daily Range

$0.02 - $0.02

52-Week Range

$0.00 - $8.99

Estimated Earnings Date

N/A

Dividend

$0.00

Beta (Volatility)

8.84 (High)

Price

$0.02

Volume

Open

$0.02

Previous Close

$0.02

Daily Range

$0.02 - $0.02

52-Week Range

$0.00 - $8.99

Estimated Earnings Date

N/A

DHAI News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Dih Us

DIH Holding US, Inc. is a healthcare technology company focusing on innovative medical solutions in rehabilitation robotics and intelligent medical devices. They integrate advanced robotics and artificial intelligence (AI) to improve patient outcomes and streamline clinical workflows. By prioritizing cutting-edge research and development, DIH positions itself as a leader in the evolving medical technology landscape. The company's growth strategies emphasize expanding their product portfolio and market reach, particularly in emerging markets with developing healthcare infrastructure.

Products and Services

Rehabilitation robotics for various therapeutic applications

Intelligent medical devices utilizing AI

Solutions that enhance clinical workflows

What Makes DIH Holding US, Inc. Special

DIH Holding US, Inc. distinguishes itself through its integration of advanced robotics and AI technologies. This creates differentiated products that improve patient recovery and increase clinical workflow efficiency. Their commitment to innovation and development of cutting-edge solutions sets them apart in the healthcare technology sector.

Five Things You Need to Know

Focuses on innovative medical technology, especially rehabilitation robotics and intelligent devices.

Integrates advanced robotics and AI to enhance patient outcomes and workflows.

Strong leadership prioritizing research and development for pioneering products.

Growth strategy targets product expansion and market penetration, particularly in emerging markets.

Engages in strategic partnerships with healthcare providers and research institutions to bolster market presence.

AI Generated • Apr 16, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

178

CEO

Jason Chen, MBA

Website

www.dih.com

Headquarters

Norwell, MA 02061, US

DHAI Financials

Key Financial Metrics (TTM)

Gross Margin

51.24%

Operating Margin

-7.74%

Net Income Margin

-13.80%

Return on Equity

24.90%

Return on Capital

N/A

Return on Assets

-32.43%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$41.90K

Shares Outstanding

2.09M

Volume

Avg. Volume

99.258

Financials (TTM)

Gross Profit

$32.04M

Operating Income

-$4.86M

EBITDA

-$7.11M

Operating Cash Flow

-$4.14M

Capital Expenditure

-$536.00K

Free Cash Flow

-$4.68M

Cash & ST Invst.

$1.94M

Total Debt

$11.96M

Dih Us Performance Analysis

Dih Us annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	USD 0	N/A
2023	2023-12-31	USD 0	N/A
2024	2024-03-31	USD 64,473,000	N/A
2025	2025-03-31	USD 62,864,000	-2.5%

Dih Us sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q1	2024-06-30	-2.3%
Q2	2024-09-30	7.1%
Q3	2024-12-31	-16.9%
Q4	2025-03-31	-16.2%

Dih Us annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	USD 6.46	N/A
2023	2023-12-31	USD 0.09	-98.6%
2024	2024-03-31	USD -8.00	N/A
2025	2025-03-31	USD -6.07	-24.2%

Dih Us sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q1	2024-06-30	87.3%
Q2	2024-09-30	61.8%
Q3	2024-12-31	-1517.6%
Q4	2025-03-31	1.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$12.65M

-27.1%

Gross Profit

$5.79M

-12.3%

Gross Margin

45.75%

N/A

Market Cap

$41.90K

N/A

Market Cap/Employee

$235.39

N/A

Employees

178

N/A

Net Income

-$4.40M

-2.6%

EBITDA

-$5.06M

-1386.8%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Total Cash

$1.94M

-39.9%

Total Debt

$11.96M

-25.0%

Accounts Receivable

$3.25M

-44.3%

Inventory

$7.05M

-14.5%

Long Term Debt

$11.77M

-18.1%

Short Term Debt

$3.12M

+98.3%

Return on Assets

-32.43%

N/A

Return on Invested Capital

30.20%

N/A

Free Cash Flow

-$3.39M

-273.9%

Operating Cash Flow

-$3.30M

-263.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

GCTKGlucoTrack, Inc.

GCTKGlucoTrack, Inc.$0.29-6.76%

TIVCTivic Health Systems, Inc.

TIVCTivic Health Systems, Inc.$0.29+1.05%

VEROVenus Concept Inc.

VEROVenus Concept Inc.$0.31+2.64%

BDRXBiodexa Pharmaceuticals Plc

BDRXBiodexa Pharmaceuticals Plc$1.65-1.79%

NAOVNanoVibronix, Inc.

NAOVNanoVibronix, Inc.$1.90+1.06%

BBLGBone Biologics Corporation

BBLGBone Biologics Corporation$1.07-0.93%

INMInMed Pharmaceuticals Inc.

INMInMed Pharmaceuticals Inc.$1.71-7.57%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$9.10-0.06%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$7.42-0.04%

ONDSOndas

ONDSOndas$7.80-0.02%

FFord Motor Company

FFord Motor Company$14.37+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.48+0.07%

CLFCleveland-Cliffs

CLFCleveland-Cliffs$11.93+0.09%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$64.00-0.03%

Questions About DHAI

What is the current price of Dih Us?

Dih Us is trading at $0.02 per share.

What is the 52-week range for Dih Us?

Over the past 52 weeks, Dih Us has traded between $0.00 and $8.99.

How much debt does Dih Us have?

As of the most recent reporting period, Dih Us reported total debt of $14.89M.

How much cash does Dih Us have on hand?

Dih Us reported $1.94M in cash and cash equivalents in its most recent financial results.

What is Dih Us’s dividend yield?

Dih Us does not currently have a dividend yield.

Dih Us(OTC) DHAI

Dih Us Financials at a Glance

DHAI News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Dih Us

Products and Services

What Makes DIH Holding US, Inc. Special

Five Things You Need to Know

DHAI Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Dih Us Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About DHAI

What is the current price of Dih Us?

What is the 52-week range for Dih Us?

How much debt does Dih Us have?

How much cash does Dih Us have on hand?

What is Dih Us’s dividend yield?

Premium Investing Services